{"transactions":[{"id":2010674,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2023-02-17T02:00:28.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":10411846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":964238},"source":{"system":"sec-edgar","filing":"0001104659-23-022971","document":"tm235636-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465923022971/tm235636-2_4seq1.xml","form_type":"4"}},{"id":2010673,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-02-17T02:00:28.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":20962895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (\"IPO\"), each share of Series A Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (\"IPO\"), each share of Series A Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (\"IPO\"), each share of Series A Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1941368},"source":{"system":"sec-edgar","filing":"0001104659-23-022971","document":"tm235636-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465923022971/tm235636-2_4seq1.xml","form_type":"4"}},{"id":2010672,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T02:00:28.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":true},"balance_after":3218106,"source":{"system":"sec-edgar","filing":"0001104659-23-022971","document":"tm235636-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465923022971/tm235636-2_4seq1.xml","form_type":"4"}},{"id":2010671,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T02:00:28.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":964238,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's IPO, each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series B Preferred Stock had no expiration date."}],"balance_after":2905606,"source":{"system":"sec-edgar","filing":"0001104659-23-022971","document":"tm235636-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465923022971/tm235636-2_4seq1.xml","form_type":"4"}},{"id":2010670,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T02:00:28.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":1941368,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (\"IPO\"), each share of Series A Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into Common Stock. These shares of Series A Preferred Stock had no expiration date."}],"balance_after":1941368,"source":{"system":"sec-edgar","filing":"0001104659-23-022971","document":"tm235636-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465923022971/tm235636-2_4seq1.xml","form_type":"4"}},{"id":2515559,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-11-12T21:16:25.000Z","date":"2021-11-09","kind":"exercise","acquired":false,"shares":188168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2365545},"source":{"system":"sec-edgar","filing":"0001104659-21-138088","document":"tm2131875-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000110465921138088/tm2131875-2_4seq1.xml","form_type":"4"}},{"id":2515558,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T21:16:25.000Z","date":"2021-11-09","kind":"purchase","acquired":true,"shares":325000,"price":14,"value":4550000.0,"ownership":{"direct":true},"balance_after":2690545,"source":{"system":"sec-edgar","filing":"0001104659-21-138088","document":"tm2131875-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000110465921138088/tm2131875-2_4seq1.xml","form_type":"4"}},{"id":2515557,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T21:16:25.000Z","date":"2021-11-09","kind":"exercise","acquired":true,"shares":2365545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date."}],"balance_after":2365545,"source":{"system":"sec-edgar","filing":"0001104659-21-138088","document":"tm2131875-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000110465921138088/tm2131875-2_4seq1.xml","form_type":"4"}},{"id":2726869,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-05-05T20:00:36.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":5426819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":625995},"source":{"system":"sec-edgar","filing":"0001104659-21-061692","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465921061692/a4.xml","form_type":"4"}},{"id":2726868,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-05T20:00:36.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":625995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":625995,"source":{"system":"sec-edgar","filing":"0001104659-21-061692","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465921061692/a4.xml","form_type":"4"}},{"id":4209233,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-09-15T00:21:16.000Z","date":"2017-09-14","kind":"sale","acquired":false,"shares":3429,"price":8.5225,"value":29223.6525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $8.5 to $8.6386. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price."}],"balance_after":2334128,"source":{"system":"sec-edgar","filing":"0001179110-17-012310","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017012310/edgar.xml","form_type":"4"}},{"id":4209232,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-09-15T00:21:16.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":22721,"price":8.5364,"value":193955.5444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $8.5 to $8.685. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price"}],"balance_after":2337557,"source":{"system":"sec-edgar","filing":"0001179110-17-012310","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017012310/edgar.xml","form_type":"4"}},{"id":4209231,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-09-15T00:21:16.000Z","date":"2017-09-12","kind":"sale","acquired":false,"shares":10458,"price":8.6284,"value":90235.8072,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $8.53 to $8.825. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The balance was adjusted by one (1) share to account for a mathematical error in a prior filing."}],"balance_after":2360278,"source":{"system":"sec-edgar","filing":"0001179110-17-012310","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017012310/edgar.xml","form_type":"4"}},{"id":4217671,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-09-06T00:18:25.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":639,"price":9.5,"value":6070.5,"ownership":{"direct":true},"balance_after":2370735,"source":{"system":"sec-edgar","filing":"0001179110-17-012037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017012037/edgar.xml","form_type":"4"}},{"id":4238708,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-10T00:54:44.000Z","date":"2017-08-08","kind":"sale","acquired":false,"shares":2013,"price":10.5003,"value":21137.1039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.51.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price."}],"balance_after":2371374,"source":{"system":"sec-edgar","filing":"0001179110-17-011313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017011313/edgar.xml","form_type":"4"}},{"id":4238707,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-10T00:54:44.000Z","date":"2017-08-07","kind":"sale","acquired":false,"shares":17790,"price":10.5,"value":186795.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.51.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price."}],"balance_after":2373387,"source":{"system":"sec-edgar","filing":"0001179110-17-011313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017011313/edgar.xml","form_type":"4"}},{"id":4247159,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-02T01:21:34.000Z","date":"2017-07-28","kind":"sale","acquired":false,"shares":6585,"price":10.508,"value":69195.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.55.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price."}],"balance_after":2391177,"source":{"system":"sec-edgar","filing":"0001179110-17-010929","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010929/edgar.xml","form_type":"4"}},{"id":4250841,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-27T01:03:28.000Z","date":"2017-07-24","kind":"sale","acquired":false,"shares":160,"price":10.5,"value":1680.0,"ownership":{"direct":true},"balance_after":2397762,"source":{"system":"sec-edgar","filing":"0001179110-17-010725","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010725/edgar.xml","form_type":"4"}},{"id":4252544,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-25T01:10:53.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":23445,"price":10.5,"value":246172.5,"ownership":{"direct":true},"balance_after":2397922,"source":{"system":"sec-edgar","filing":"0001179110-17-010640","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010640/edgar.xml","form_type":"4"}},{"id":4252543,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-25T01:10:53.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":20786,"price":10.5,"value":218253.0,"ownership":{"direct":true},"balance_after":2421367,"source":{"system":"sec-edgar","filing":"0001179110-17-010640","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010640/edgar.xml","form_type":"4"}},{"id":4253157,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-22T01:36:12.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":23445,"price":10.5,"value":246172.5,"ownership":{"direct":true},"balance_after":2397922,"source":{"system":"sec-edgar","filing":"0001179110-17-010624","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010624/edgar.xml","form_type":"4"}},{"id":4253156,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-22T01:36:12.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":20786,"price":10.5,"value":218253.0,"ownership":{"direct":true},"balance_after":2421367,"source":{"system":"sec-edgar","filing":"0001179110-17-010624","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010624/edgar.xml","form_type":"4"}},{"id":4255136,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-19T01:03:25.000Z","date":"2017-07-18","kind":"sale","acquired":false,"shares":1339,"price":10.5,"value":14059.5,"ownership":{"direct":true},"balance_after":2442153,"source":{"system":"sec-edgar","filing":"0001179110-17-010441","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010441/edgar.xml","form_type":"4"}},{"id":4255135,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-19T01:03:25.000Z","date":"2017-07-17","kind":"sale","acquired":false,"shares":47460,"price":10.5018,"value":498415.428,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.64. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2443492,"source":{"system":"sec-edgar","filing":"0001179110-17-010441","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010441/edgar.xml","form_type":"4"}},{"id":4255134,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-19T01:03:25.000Z","date":"2017-07-14","kind":"sale","acquired":false,"shares":21055,"price":10.5338,"value":221789.159,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions  ranging from $10.50 to $10.64. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2490952,"source":{"system":"sec-edgar","filing":"0001179110-17-010441","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010441/edgar.xml","form_type":"4"}},{"id":4257627,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-14T01:22:09.000Z","date":"2017-07-13","kind":"sale","acquired":false,"shares":39914,"price":10.5416,"value":420757.4224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2512007,"source":{"system":"sec-edgar","filing":"0001179110-17-010365","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010365/edgar.xml","form_type":"4"}},{"id":4257626,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-14T01:22:09.000Z","date":"2017-07-12","kind":"sale","acquired":false,"shares":13740,"price":10.5001,"value":144271.374,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.52 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2551921,"source":{"system":"sec-edgar","filing":"0001179110-17-010365","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010365/edgar.xml","form_type":"4"}},{"id":4257625,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-14T01:22:09.000Z","date":"2017-07-11","kind":"sale","acquired":false,"shares":3521,"price":10.5161,"value":37027.1881,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.59 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2565661,"source":{"system":"sec-edgar","filing":"0001179110-17-010365","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010365/edgar.xml","form_type":"4"}},{"id":4260764,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-08T01:29:52.000Z","date":"2017-07-07","kind":"sale","acquired":false,"shares":133,"price":10.5,"value":1396.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 23, 2017, Nabriva Therapeutics plc (\"Nabriva plc\") became the successor of Nabriva Therapeutics AG (\"Nabriva AG\") pursuant to an exchange offer.  Pursuant to the exchange offer, each outstanding common share of Nabriva AG was exchanged for ten ordinary shares of Nabriva plc and each outstanding American Depositary Share of Nabriva AG, which represented one-tenth of one common share of Nabriva AG, was exchanged for one ordinary share of Nabriva plc.  On prior reports filed by the reporting person subsequent to the completion of the exchange offer, all references to American Depositary Shares of Nabriva AG should be understood to refer to ordinary shares of Nabriva plc.."}],"balance_after":2569182,"source":{"system":"sec-edgar","filing":"0001179110-17-010236","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010236/edgar.xml","form_type":"4"}},{"id":4260763,"issuer":{"id":174291,"kind":"organization","name":"Nabriva Therapeutics Legacy plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-07-08T01:29:52.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":2562,"price":10.5232,"value":26960.4384,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 23, 2017, Nabriva Therapeutics plc (\"Nabriva plc\") became the successor of Nabriva Therapeutics AG (\"Nabriva AG\") pursuant to an exchange offer.  Pursuant to the exchange offer, each outstanding common share of Nabriva AG was exchanged for ten ordinary shares of Nabriva plc and each outstanding American Depositary Share of Nabriva AG, which represented one-tenth of one common share of Nabriva AG, was exchanged for one ordinary share of Nabriva plc.  On prior reports filed by the reporting person subsequent to the completion of the exchange offer, all references to American Depositary Shares of Nabriva AG should be understood to refer to ordinary shares of Nabriva plc.."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $10.50 to $10.74 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2569315,"source":{"system":"sec-edgar","filing":"0001179110-17-010236","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010236/edgar.xml","form_type":"4"}},{"id":4263743,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-07-06T00:58:17.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":11352,"price":10.9452,"value":124249.9104,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $10.59 to $11.12. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2571877,"source":{"system":"sec-edgar","filing":"0001179110-17-010135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010135/edgar.xml","form_type":"4"}},{"id":4263742,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-07-06T00:58:17.000Z","date":"2017-06-30","kind":"sale","acquired":false,"shares":1775,"price":10.9411,"value":19420.4525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These ADSs were sold in multiple transactions ranging from $10.50 to $11.08  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2583229,"source":{"system":"sec-edgar","filing":"0001179110-17-010135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017010135/edgar.xml","form_type":"4"}},{"id":4270076,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-06-30T01:33:40.000Z","date":"2017-06-29","kind":"sale","acquired":false,"shares":1603,"price":10.723,"value":17188.969,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $10.61 to $10.81. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2585004,"source":{"system":"sec-edgar","filing":"0001179110-17-009806","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017009806/edgar.xml","form_type":"4"}},{"id":4270075,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-06-30T01:33:40.000Z","date":"2017-06-28","kind":"sale","acquired":false,"shares":4789,"price":11.1,"value":53157.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2586697,"source":{"system":"sec-edgar","filing":"0001179110-17-009806","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017009806/edgar.xml","form_type":"4"}},{"id":4270074,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-06-30T01:33:40.000Z","date":"2017-06-27","kind":"sale","acquired":false,"shares":2166,"price":10.8297,"value":23457.1302,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These ADSs were sold in multiple transactions ranging from $10.50 to $11.16.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2591396,"source":{"system":"sec-edgar","filing":"0001179110-17-009806","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017009806/edgar.xml","form_type":"4"}},{"id":4292599,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-06-06T01:41:08.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":400,"price":11.27,"value":4508.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."}],"balance_after":2593562,"source":{"system":"sec-edgar","filing":"0001179110-17-008647","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017008647/edgar.xml","form_type":"4"}},{"id":4341953,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-28T23:13:04.000Z","date":"2017-04-28","kind":"sale","acquired":false,"shares":15130,"price":11.0253,"value":166812.789,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.00 to $11.15. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2593962,"source":{"system":"sec-edgar","filing":"0001179110-17-006295","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006295/edgar.xml","form_type":"4"}},{"id":4341952,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-28T23:13:04.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":100,"price":11,"value":1100.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."}],"balance_after":2609092,"source":{"system":"sec-edgar","filing":"0001179110-17-006295","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006295/edgar.xml","form_type":"4"}},{"id":4341951,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-28T23:13:04.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":709,"price":11,"value":7799.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."}],"balance_after":2609192,"source":{"system":"sec-edgar","filing":"0001179110-17-006295","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006295/edgar.xml","form_type":"4"}},{"id":4345453,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-25T23:19:42.000Z","date":"2017-04-21","kind":"sale","acquired":false,"shares":2622,"price":11.0364,"value":28937.4408,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."}],"balance_after":2609901,"source":{"system":"sec-edgar","filing":"0001179110-17-006201","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006201/edgar.xml","form_type":"4"}},{"id":4348543,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-21T00:29:17.000Z","date":"2017-04-20","kind":"sale","acquired":false,"shares":325,"price":11,"value":3575.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."}],"balance_after":2612523,"source":{"system":"sec-edgar","filing":"0001179110-17-006134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006134/edgar.xml","form_type":"4"}},{"id":4348542,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-21T00:29:17.000Z","date":"2017-04-19","kind":"sale","acquired":false,"shares":11785,"price":11.0678,"value":130434.023,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.05 to $11.20. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2612848,"source":{"system":"sec-edgar","filing":"0001179110-17-006134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006134/edgar.xml","form_type":"4"}},{"id":4348541,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-21T00:29:17.000Z","date":"2017-04-18","kind":"sale","acquired":false,"shares":11822,"price":11.1555,"value":131880.321,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.13 to $11.20. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2624633,"source":{"system":"sec-edgar","filing":"0001179110-17-006134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017006134/edgar.xml","form_type":"4"}},{"id":4352477,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-14T01:12:33.000Z","date":"2017-04-13","kind":"sale","acquired":false,"shares":10984,"price":11.1282,"value":122232.1488,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.10 to $11.20. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2636455,"source":{"system":"sec-edgar","filing":"0001179110-17-005990","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005990/edgar.xml","form_type":"4"}},{"id":4352476,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-14T01:12:33.000Z","date":"2017-04-12","kind":"sale","acquired":false,"shares":13250,"price":11.2191,"value":148653.075,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.20 to $11.50. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2647439,"source":{"system":"sec-edgar","filing":"0001179110-17-005990","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005990/edgar.xml","form_type":"4"}},{"id":4352475,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-14T01:12:33.000Z","date":"2017-04-11","kind":"sale","acquired":false,"shares":8597,"price":11.4033,"value":98034.1701,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share.  The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.00 to $11.50. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2660689,"source":{"system":"sec-edgar","filing":"0001179110-17-005990","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005990/edgar.xml","form_type":"4"}},{"id":4354342,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-11T10:04:28.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":37876,"price":10.7311,"value":406451.1436,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The prices reported in Column 4 are weighted average prices. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2669286,"source":{"system":"sec-edgar","filing":"0001104659-17-022745","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465917022745/a4a.xml","form_type":"4/A","original_submission_date":"2017-04-10"}},{"id":4354341,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-11T10:04:28.000Z","date":"2017-04-07","kind":"sale","acquired":false,"shares":18001,"price":10.96,"value":197290.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The prices reported in Column 4 are weighted average prices. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2707162,"source":{"system":"sec-edgar","filing":"0001104659-17-022745","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465917022745/a4a.xml","form_type":"4/A","original_submission_date":"2017-04-10"}},{"id":4354340,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-11T10:04:28.000Z","date":"2017-04-07","kind":"sale","acquired":false,"shares":3500,"price":11.04,"value":38640.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The prices reported in Column 4 are weighted average prices. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2725163,"source":{"system":"sec-edgar","filing":"0001104659-17-022745","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465917022745/a4a.xml","form_type":"4/A","original_submission_date":"2017-04-10"}},{"id":4354339,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-11T10:04:28.000Z","date":"2017-04-06","kind":"sale","acquired":false,"shares":24600,"price":11.2,"value":275520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The prices reported in Column 4 are weighted average prices. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2728663,"source":{"system":"sec-edgar","filing":"0001104659-17-022745","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465917022745/a4a.xml","form_type":"4/A","original_submission_date":"2017-04-10"}},{"id":4354338,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"American Depository Shares representing Common Shares","published_at":"2017-04-11T10:04:28.000Z","date":"2017-04-06","kind":"sale","acquired":false,"shares":6617,"price":11.28,"value":74639.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depository Share of the Issuer (\"ADS\") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The prices reported in Column 4 are weighted average prices. These ADSs were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":2753263,"source":{"system":"sec-edgar","filing":"0001104659-17-022745","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000110465917022745/a4a.xml","form_type":"4/A","original_submission_date":"2017-04-10"}},{"id":4355235,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-04-11T01:38:01.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":37876,"price":10.7311,"value":406451.1436,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were sold in multiple transactions.Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":185394,"source":{"system":"sec-edgar","filing":"0001179110-17-005914","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005914/edgar.xml","form_type":"4"}},{"id":4355234,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-04-11T01:38:01.000Z","date":"2017-04-07","kind":"sale","acquired":false,"shares":18001,"price":10.96,"value":197290.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were sold in multiple transactions.Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":223270,"source":{"system":"sec-edgar","filing":"0001179110-17-005914","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005914/edgar.xml","form_type":"4"}},{"id":4355233,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-04-11T01:38:01.000Z","date":"2017-04-07","kind":"sale","acquired":false,"shares":3500,"price":11.04,"value":38640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were sold in multiple transactions.Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":241271,"source":{"system":"sec-edgar","filing":"0001179110-17-005914","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005914/edgar.xml","form_type":"4"}},{"id":4355232,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-04-11T01:38:01.000Z","date":"2017-04-06","kind":"sale","acquired":false,"shares":24600,"price":11.2,"value":275520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were sold in multiple transactions.Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":244771,"source":{"system":"sec-edgar","filing":"0001179110-17-005914","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005914/edgar.xml","form_type":"4"}},{"id":4355231,"issuer":{"id":111497,"kind":"organization","name":"Nabriva Therapeutics plc","symbol":"NBRV"},"owners":[{"id":116796,"kind":"organization","name":"HBM Healthcare Investments (Cayman) Ltd.","position":1,"cik":"0001232258","reported_name":"HBM Healthcare Investments (Cayman) Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-04-11T01:38:01.000Z","date":"2017-04-06","kind":"sale","acquired":false,"shares":6617,"price":11.28,"value":74639.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were sold in multiple transactions.Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price."}],"balance_after":269371,"source":{"system":"sec-edgar","filing":"0001179110-17-005914","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232258/000117911017005914/edgar.xml","form_type":"4"}}]}